LYRA THERAPEUTICS
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat diseases. The company’s proprietary technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. The company’s initial product candidates, LYR-210 and LYR-... 220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of CRS. The therapeutic embedded within LYR-210 and LYR-220 is mometasone furoate, which is the active ingredient in various FDA-approved drugs and has a well-established efficacy and safety profile.
LYRA THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics Wellness
Founded:
2005-01-01
Address:
Watertown, Massachusetts, United States
Country:
United States
Website Url:
http://www.lyratherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
617.393.4600
Email Addresses:
[email protected]
Total Funding:
214.09 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Dystrogen Therapeutics
Dystrogen Therapeutics is a clinical-stage regenerative medicine company focusing on rare diseases.
Eliem Therapeutics
Eliem Therapeutics is a clinical-stage biotechnology company developing treatments for nervous system disorders.
Keeps
Keeps is a startup aimed at preventing and slowing age-related hair loss.
Koya Medical
Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.
LifeGuides, PBC
Modernizing human support & learning - The Marketplace for Life Experience. More casual than therapy, more qualified than a friend. B2B SaaS
Lyndra Therapeutics
Lyndra Therapeutics is a novel technology platform reinventing medicine for a healthier world.
MBX Biosciences
MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.
Medable
Medable is transforming clinical research and predictive medicine by creating a platform powered by patient generated data.
NorthSea Therapeutics
NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
OneSkin
OneSkin is a longevity company developing products designed to extend skin and body health by targeting aging at its source.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Primaeva Medical
Primaeva Medical is a venture capital funded company developing devices for dermatologists, plastic surgeons and other cosmetic physicians.
Pure Scientific Technologies
Pure Scientific Technologies is a medical device startup company that develops a new patent-pending drug delivery system.
Thermaband
Thermaband is a health and wellness company empowering menopausal women with personal comfort on demand through a cooling/warming wearable.
Treadwell Therapeutics
Treadwell Therapeutics is a clinical-stage oncology company that develops medicines to address unmet needs in patients with cancer.
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - Lyra Therapeutics
Samsara BioCapital
Samsara BioCapital investment in Post-IPO Equity - Lyra Therapeutics
North Bridge Venture Partners & Growth Equity
North Bridge Venture Partners & Growth Equity investment in Post-IPO Equity - Lyra Therapeutics
Nantahala Capital Management
Nantahala Capital Management investment in Post-IPO Equity - Lyra Therapeutics
Pura Vida Investments
Pura Vida Investments investment in Post-IPO Equity - Lyra Therapeutics
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Post-IPO Equity - Lyra Therapeutics
RA Capital Management
RA Capital Management investment in Series C - Lyra Therapeutics
Soleus Capital
Soleus Capital investment in Series C - Lyra Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Series C - Lyra Therapeutics
Polaris Partners
Polaris Partners investment in Series C - Lyra Therapeutics
Key Employee Changes
Official Site Inspections
http://www.lyratherapeutics.com Semrush global rank: 4.67 M Semrush visits lastest month: 2.09 K
- Host name: 169.101.198.104.bc.googleusercontent.com
- IP address: 104.198.101.169
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
